These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33125756)

  • 21. Surgical Resection of the Primary Tumor in Stage IV Colorectal Cancer Without Metastasectomy is Associated With Improved Overall Survival Compared With Chemotherapy/Radiation Therapy Alone.
    Gulack BC; Nussbaum DP; Keenan JE; Ganapathi AM; Sun Z; Worni M; Migaly J; Mantyh CR
    Dis Colon Rectum; 2016 Apr; 59(4):299-305. PubMed ID: 26953988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
    Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
    Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metastatic Colorectal Cancer in Young Adults: A Study From the South Australian Population-Based Registry.
    Vatandoust S; Price TJ; Ullah S; Roy AC; Beeke C; Young JP; Townsend A; Padbury R; Roder D; Karapetis CS
    Clin Colorectal Cancer; 2016 Mar; 15(1):32-6. PubMed ID: 26341410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer.
    Pietrantonio F; Di Nicolantonio F; Schrock AB; Lee J; Tejpar S; Sartore-Bianchi A; Hechtman JF; Christiansen J; Novara L; Tebbutt N; Fucà G; Antoniotti C; Kim ST; Murphy D; Berenato R; Morano F; Sun J; Min B; Stephens PJ; Chen M; Lazzari L; Miller VA; Shoemaker R; Amatu A; Milione M; Ross JS; Siena S; Bardelli A; Ali SM; Falcone A; de Braud F; Cremolini C
    J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29370427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of mortality in metastatic colorectal cancer in a real-life population: a multicenter explorative analysis.
    Rumpold H; Niedersüß-Beke D; Heiler C; Falch D; Wundsam HV; Metz-Gercek S; Piringer G; Thaler J
    BMC Cancer; 2020 Nov; 20(1):1149. PubMed ID: 33238958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Impact of Primary Tumor Location on Clinical Outcomes of Metastatic Colorectal Cancer Treated With Cetuximab Plus Oxaliplatin-Based Chemotherapy: A Subgroup Analysis of the JACCRO CC-05/06 Trials.
    Sunakawa Y; Ichikawa W; Tsuji A; Denda T; Segawa Y; Negoro Y; Shimada K; Kochi M; Nakamura M; Kotaka M; Tanioka H; Takagane A; Tani S; Yamaguchi T; Watanabe T; Takeuchi M; Fujii M; Nakajima T
    Clin Colorectal Cancer; 2017 Sep; 16(3):e171-e180. PubMed ID: 27856123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer.
    Zhang BY; Jones JC; Briggler AM; Hubbard JM; Kipp BR; Sargent DJ; Dixon JG; Grothey A
    Clin Colorectal Cancer; 2017 Jun; 16(2):124-128. PubMed ID: 27726953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of Tumor Location to Clinical Outcomes in Colorectal Cancer: A Single-institution Retrospective Analysis.
    Signorelli C; Chilelli MG; Sperduti I; Giacinti S; Amodio PM; Palmieri RM; Ranalli TV; Gomes VV; Rosetto ME; Nelli F; Ruggeri EM
    Anticancer Res; 2019 Sep; 39(9):4917-4924. PubMed ID: 31519596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary tumor location and survival among metastatic colorectal cancer patients treated with systemic chemotherapy and biologic therapies: Retrospective analysis.
    Ramadan M; Alfayea T; Alsofyani A; Alyabsi M; Alhusseini N; Algarni AS
    Cancer Treat Res Commun; 2022; 33():100632. PubMed ID: 36088745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of outcomes and treatment safety of patients with metastatic colorectal cancer to the liver with estimation of prognostic factors.
    Zeman M; Maciejewski A; Półtorak S; Kryj M
    Pol Przegl Chir; 2013 Jun; 85(6):333-9. PubMed ID: 23828415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary tumor location as a predictor of the benefit of palliative resection for colorectal cancer with unresectable metastasis.
    Zhang RX; Ma WJ; Gu YT; Zhang TQ; Huang ZM; Lu ZH; Gu YK
    World J Surg Oncol; 2017 Jul; 15(1):138. PubMed ID: 28750680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of tumour site on prognosis in metastatic colorectal carcinomas with primary tumour resection.
    Merkel S; Schellerer VS; Wein A; Semrau S; Geppert C; Göhl J; Hohenberger W; Weber K; Grützmann R
    Int J Colorectal Dis; 2018 Sep; 33(9):1215-1223. PubMed ID: 29915904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver only metastatic disease in patients with metastatic colorectal cancer: impact of surgery and chemotherapy.
    Padman S; Padbury R; Beeke C; Karapetis CS; Bishnoi S; Townsend AR; Maddern G; Price TJ
    Acta Oncol; 2013 Nov; 52(8):1699-706. PubMed ID: 24102180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colorectal hepatic metastases: resection, local ablation, and hepatic artery infusion pump are associated with prolonged survival.
    Heslin MJ; Medina-Franco H; Parker M; Vickers SM; Aldrete J; Urist MM
    Arch Surg; 2001 Mar; 136(3):318-23. PubMed ID: 11231853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lung Metastasis Predicts Better Prognosis in Metastatic Colorectal Cancer With Mutated KRAS.
    Margalit O; Shacham-Shmueli E; Lawrence YR; Yang YX; Reiss KA; Golan T; Mamtani R; Halpern N; Aderka D; Giantonio B; Boursi B
    Clin Colorectal Cancer; 2019 Sep; 18(3):e300-e307. PubMed ID: 31324478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer.
    Boisen MK; Johansen JS; Dehlendorff C; Larsen JS; Østerlind K; Hansen J; Nielsen SE; Pfeiffer P; Tarpgaard LS; Holländer NH; Keldsen N; Hansen TF; Jensen BB; Jensen BV
    Ann Oncol; 2013 Oct; 24(10):2554-2559. PubMed ID: 23864097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signet ring cell carcinoma of resectable metastatic colorectal cancer has rare surgical value.
    Fu J; Wu L; Jiang M; Tan Y; Li D; Chen F; Jiang T; Du J
    J Surg Oncol; 2016 Dec; 114(8):1004-1008. PubMed ID: 27891617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does Primary Tumor Side Matter in Patients with Metastatic Colon Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy?
    Kelly KJ; Alsayadnasser M; Vaida F; Veerapong J; Baumgartner JM; Patel S; Ahmad S; Barone R; Lowy AM
    Ann Surg Oncol; 2019 May; 26(5):1421-1427. PubMed ID: 30815802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Association of Tumor Laterality and Survival After Cytoreduction for Colorectal Carcinomatosis.
    Blakely AM; Lafaro KJ; Eng OS; Ituarte PHG; Fakih M; Lee B; Raoof M
    J Surg Res; 2020 Apr; 248():20-27. PubMed ID: 31841733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of survival after liver resection for metastatic colorectal carcinoma.
    Parau A; Todor N; Vlad L
    J BUON; 2015; 20(1):68-77. PubMed ID: 25778299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.